Notch4 is proposed as a less differentiated marker for glioma cells, and Notch4 expression increases from low-grade astrocytoma to high-graded GBM (El Hindy et al., 2013; Dell'albani et al., 2014). This evidence concerns the gene NOTCH4 and central nervous system cancer.